This post is not the latest immunisation update and therefore may contain information or advice that is out of date. Please see our most recent update here.
Disease notification – Which conditions are GPs required to report?
The Public Health Act 2010 requires that certain medical conditions be notified to the relevant NSW public health unit -all notifications are kept strictly confidential. All GPs are required to report notifiable conditions to their local PHU on the basis of reasonable clinical suspicion. Case notification should be initiated within 24 hours of diagnosis. Some notifiable conditions include: measles, monkeypox, and pertussis (whooping cough).
GPs must also notify the PHU by phone on 1300 066 055 if the notifiable disease is followed by a phone icon ☎ on the notification form
See National Notifiable Diseases Surveillance System NNDSS fortnightly reports for 22 August to 4 September 2022.
ANIs and RACFs now able to apply for an AIR provider number
Authorised Nurses Immunisers (ANIs) and Residential Care Facilities (RCFs) can now apply for an AIR Provider Number to access the online Australian Immunisation Register (AIR). To apply for an AIR provider number complete the IM004 form and email to MOH-VaccReports@health.nsw.gov.au
ANIs require an ABN to register for their own AIR provider number. ANIs without an ABN can be delegated AIR access from the organisation that employs them or a health professional.
Registered nurses interested in becoming a qualified ANI are encouraged to apply for CESPHN’s Nurse Scholarship to complete the training course and attain this qualification. For more information about the scholarship and to apply, see CESPHN Immunisation website. Applications close 30 September 2022. For further information, see the latest Australian Immunisation Register Update – 19 September 2022.
Monkeypox vaccine – New clinics, referral process and administration advice
Subcutaneous vs Intradermal administration
JYNNEOS monkeypox vaccine was initially administered by subcutaneous injection, however updated clinical guidance from the ATAGI now allows intradermal administration of JYNNEOS monkeypox vaccine in individuals who are not severely immunocompromised and are receiving the vaccine before exposure to monkeypox virus (pre-exposure prophylaxis). AusVaxSafety is monitoring the different vaccine delivery methods and whether there is any impact on side effects.
Referral to Mallett St clinic: GPs can provide referrals to eligible patients – the clinic will take walk-in referrals from GPs or appointments can scheduled by contacting clinic on 0460 013 803 between 9am and 4pm
Referral to Crown St clinic: GPs can directly refer eligible patients for MPX vaccination by calling Sexual Health Info Link (SHIL) on 1800 451 624
Expression of interest: patients can self-register their interest for the MPX vaccine by completing the NSW Health form
Latest MPX webinar:
Watch a recording of CESPHN’s Monkeypox webinar where PHU director Dr Vicky Sheppeard and Infectious Diseases physician Dr Kasha Singh speak about the MPX outbreak situation in CESPHN, vaccination rollout, identification, treatment, and case management.
GPs, practice nurses and pharmacists needed
Researchers at NCIRS are conducting a study to investigate the use of vaccine safety surveillance systems in order to improve and ensure they are fit-for-purpose for the needs of immunisation providers and patients.
GPs, practice nurses and pharmacists are invited to participatein a short telephone or videoconference interview to share your experiences – good, bad or non-existent – with vaccine safety surveillance systems in your daily practice. Participants will be given a voucher for their time and interviews will take place throughout October and November. Registrations close 30 October 2022.
The research was required to understand current attitudes, barriers, motivators and information needs relating to uptake of Influenza vaccines. The findings from the research will be used to inform strategic approaches to address any structural or attitudinal barriers to the uptake of influenza vaccines amongst the general population and key target audiences in future seasons.
Guidance name changed to include all COVID19 vaccine(s), not just mRNA
Updated rates of myocarditis and pericarditis following COVID-19 vaccination by age, gender, and dose
Updated evidence on the long-term outcomes of people with myocarditis or pericarditis following vaccination
Updated recommendations for revaccination in people with a history of myocarditis or pericarditis following vaccination
Third primary dose in severely immunocompromised – updated recommendations
On 23 September 2022, ATAGI recommendations on the use of a third primary dose of COVID-19 vaccine in individuals who are severely immunocompromised were updated.
What has changed:
ATAGI recommends all individuals aged 6 months and over with certain conditions or on therapies leading to severe immunocompromise to receive a 3rd primary dose of a COVID-19 vaccine.
Novavax can also be used as 3rd primary dose for Immunocompromised populations, however an mRNA COVID-19 vaccine (Pfizer or Moderna) is preferred
Webinars: Upcoming and recorded
COVID-19 response update
About: primary care update on the COVID-19 response and the vaccine rollout – key updates and Q&A
When: Thursday | 29 September 2022 | 12:00pm **note new time**
Speak up for the community: Do you know someone who could give great input about health needs and services? voices4health is the place where people living in central and eastern Sydney can contribute to decision-making about health needs and services in the area where they live. This is a place…
Stay alert for meningococcal symptoms NSW Health is urging health professionals to be on alert for symptoms of meningococcal disease and act immediately if they appear after the notification of three recent cases. So far this year, there have been 19 cases of meningococcal disease reported in NSW. The majority…
Nominate or Apply for the 2023 CESPHN Primary Health Awards: The annual Central and Eastern Sydney PHN (CESPHN) Health Awards recognises primary health care professionals and organisations that have provided exceptional service or an outstanding contribution to primary health care in the Central and Eastern region of Sydney during the…
Speak up for the Community: Are you interested in having a say about health needs and health services in your area? voices4health is the place where people living in central and eastern Sydney can contribute to decision-making about health needs and services in the area where they live. This is…
FIVE QUESTIONS is where we ask members of the community to talk about how they stay HEALTHY. General Manager First Nations Fashion + Design and Wiradjuri Woman living on Dharawal Country Emma Griggs (pictured below at the recent Australian Fashion Week 2023 at Carriageworks, Gadigal land), shared this: 1. What did…
Study Invitation for Parents of Children with Eczema: A research team at Western Sydney University is seeking parents for a study exploring their perspectives around topical steroid use for eczema management. Participants will be involved in a virtual (via Zoom or telephone) interview, which will take up to 1 hour….